Table 1. Descriptive characteristics of study population.
| Men (n = 7,401) | Women (n = 5,586) | p value | |
|---|---|---|---|
| Age (years) | 53.8 ± 12.1 | 56.4 ± 12.0 | < 0.001 |
| Body mass index (kg/m2) | 25.2 ± 2.9 | 24.5 ± 3.4 | < 0.001 |
| White blood cell (/mm3) | 6106.0 ± 1470.6 | 5528.0 ± 1462.2 | < 0.001 |
| Neutrophil (/mm3) | 3370.0 ±1118.4 | 3104.5 ± 1154.8 | < 0.001 |
| Lymphocyte (/mm3) | 2103.3 ± 614.4 | 1932.6 ± 594.4 | < 0.001 |
| Monocyte (/mm3) | 394.4 ± 142.6 | 329.4 ± 121.8 | < 0.001 |
| Fasting plasma glucose (mg/dL) | 120.2 ± 37.5 | 118.5 ± 38.1 | 0.293 |
| HbA1c | 5.70 (5.40–6.00) | 5.60 (5.35–6.00) | <0.001 |
| Total cholesterol (mg/dL) | 200.4 ± 36.6 | 202.5 ± 38.0 | 0.001 |
| Triglycerides (mg/dL) | 150.6 ± 96.8 | 113.1 ± 77.7 | <0.001 |
| HDL-cholesterol (mg/dL) | 51.3 ± 12.4 | 59.2 ± 14.4 | < 0.001 |
| LDL-cholesterol (mg/dL) | 109.3 ± 26.5 | 107.8 ± 28.0 | 0.003 |
| hsCRP | 0.01 (0.01–0.19) | 0.01 (0.01–0.14) | <0.001 |
| Diabetes | 1282 (17.7%) | 712 (13.1%) | <0.001 |
| Hypertension | 2735 (37.6%) | 1721 (31.4%) | <0.001 |
| Lipid-lowering agents | 1076 (14.5%) | 665 (11.9%) | <0.001 |
| Coronary artery calcium scores | 50.1 ± 243.5 | 27.1 ± 138.9 | <0.001 |
| >50% stenosis | 661 (9.1%) | 261 (4.8%) | <0.001 |
| Plaque | <0.001 | ||
| Calcified | 2104 (28.4%) | 895 (16.0%) | |
| Non-calcified | 5297 (71.6%) | 4691 (84.0%) | |
| Multiple vessel involvement | 202 (2.8%) | 74 (1.4%) | <0.001 |
Data area shown as mean ± standard deviation (SD), median (interquantile range) or n (%). HbA1C, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hsCRP, highly sensitive C-reactive protein